Cranbrook Wealth Management’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

Cranbrook Wealth Management’s Portfolio PLXP Stock Details PLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,500	Closed	-$976	–	293
2023 Q1	$976	Hold	7,500	–	–	﹤0.01%	279
2022 Q4	$1.23K	Hold	7,500	–	–	﹤0.01%	269
2022 Q3	$5K	Hold	7,500	–	–	﹤0.01%	270
2022 Q2	$18K	Hold	7,500	–	–	﹤0.01%	221
2022 Q1	$30K	Hold	7,500	–	–	0.01%	220
2021 Q4	$60K	Hold	7,500	–	–	0.01%	166
2021 Q3	$145K	Hold	7,500	–	–	0.03%	117
2021 Q2	$104K	Hold	7,500	–	–	0.02%	130
2021 Q1	$68K	Hold	7,500	–	–	0.02%	157
2020 Q4	$41K	Hold	7,500	–	–	0.01%	171
2020 Q3	$24K	Hold	7,500	–	–	0.01%	175
2020 Q2	$24K	Hold	7,500	–	–	0.01%	172
2020 Q1	$17K	Hold	7,500	–	–	0.01%	175
2019 Q4	$33K	Hold	7,500	–	–	0.01%	157
2019 Q3	$38K	Hold	7,500	–	–	0.01%	147
2019 Q2	$54K	Hold	7,500	–	–	0.02%	129
2019 Q1	$39K	Hold	7,500	–	–	0.01%	142
2018 Q4	$11K	Hold	7,500	–	–	﹤0.01%	184
2018 Q3	$30K	Buy	+7,500	New	+$28.2K	0.01%	143

Other funds holding PLXP

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Cranbrook Wealth Management's PLXP Position: Q2 2023 in Review

Cranbrook Wealth Management sold out of PLx Pharma Inc. Common Stock (PLXP) in Q2 2023, closing a stake of 7,500 shares — an estimated $976 sold.

Cranbrook Wealth Management first reported a position in PLXP in Q3 2018 and held it in 19 quarters. The position peaked at $145K in Q3 2021. 4 funds tracked by Wall St. Rank hold PLXP as of Q2 2023.

Cranbrook Wealth Management reported no remaining PLx Pharma Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Cranbrook Wealth Management sold 7,500 PLx Pharma Inc. Common Stock shares in Q2 2023, an estimated $976.
Cranbrook Wealth Management first reported a position in PLx Pharma Inc. Common Stock in Q3 2018 and held it in 19 quarters.
Cranbrook Wealth Management's PLx Pharma Inc. Common Stock position peaked at $145K in Q3 2021.
4 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q2 2023.

Based on Cranbrook Wealth Management's 13F filing for Q2 2023, filed 17 Jul 2023.